Hypera S.A.'s (BVMF:HYPE3) robust earnings report didn't manage to move the market for its stock. We did some digging, and we found some concerning factors in the details.
One essential aspect of assessing earnings quality is to look at how much a company is diluting shareholders. Hypera expanded the number of shares on issue by 11% over the last year. Therefore, each share now receives a smaller portion of profit. To celebrate net income while ignoring dilution is like rejoicing because you have a single slice of a larger pizza, but ignoring the fact that the pizza is now cut into many more slices. Check out Hypera's historical EPS growth by clicking on this link.
A Look At The Impact Of Hypera's Dilution On Its Earnings Per Share (EPS)
You can see above that Hypera's profit is about the same as it was three years back. In contrast, its earnings per share is down 0.8% per year over the same period. The 107% increase in profit would have impressed many. Then again, EPS was only up 107% over that period. Therefore, the dilution is having a noteworthy influence on shareholder returns.
In the long term, earnings per share growth should beget share price growth. So Hypera shareholders will want to see that EPS figure continue to increase. However, if its profit increases while its earnings per share stay flat (or even fall) then shareholders might not see much benefit. For the ordinary retail shareholder, EPS is a great measure to check your hypothetical "share" of the company's profit.
That might leave you wondering what analysts are forecasting in terms of future profitability. Luckily, you can click here to see an interactive graph depicting future profitability, based on their estimates.
Our Take On Hypera's Profit Performance
Hypera shareholders should keep in mind how many new shares it is issuing, because, dilution clearly has the power to severely impact shareholder returns. Because of this, we think that it may be that Hypera's statutory profits are better than its underlying earnings power. But the happy news is that, while acknowledging we have to look beyond the statutory numbers, those numbers are still improving, with EPS growing at a very high rate over the last year. Of course, we've only just scratched the surface when it comes to analysing its earnings; one could also consider margins, forecast growth, and return on investment, among other factors. If you'd like to know more about Hypera as a business, it's important to be aware of any risks it's facing. Every company has risks, and we've spotted 2 warning signs for Hypera (of which 1 doesn't sit too well with us!) you should know about.
Today we've zoomed in on a single data point to better understand the nature of Hypera's profit. But there is always more to discover if you are capable of focussing your mind on minutiae. Some people consider a high return on equity to be a good sign of a quality business. So you may wish to see this free collection of companies boasting high return on equity, or this list of stocks with high insider ownership.
Valuation is complex, but we're here to simplify it.
Discover if Hypera might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
mitchell_lawlerMicron (MU) is booming, and it still doesn't look ‘expensive’ based on next year's earnings. So why does our own valuation say it could be worth 40% less?
A low price to earnings ratio at the top of the cycle is a warning rather than a bargain, and a terrifyingly high one at the bottom is often the entry point
Memory used to have a dozen participants racing each other into oversupply, and now it has three. High bandwidth memory is qualified into customer designs years ahead, sold under long-term agreements, and is far harder to switch away from than commodity DRAM.
About BOVESPA:HYPE3
Hypera
Operates as a pharmaceutical company in Brazil.
Very undervalued with proven track record and pays a dividend.
Similar Companies
Market Insights
Weekly Picks

The 1960s Fighter Jet That Could Crack Open a $20 Billion Satellite Market

The Short and Long Term Compounder of Liquid Cooling industry.

I Fell in Love With a Data-Center Cooling Stock. Then I Opened the Filings.

The Cheap Genius Problem
Recently Updated Narratives
Fair Price 80$ eventually 100$ depending on the market share futuro
Meta’s Valuation Still Works, But Only If Free Cash Flow Recovers
Triodos Bank: The Market Still Looks Stuck On The Trading Saga, But The Valuation Case Is Starting To Shift
Popular Narratives

